HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lars Matuszewski Selected Research

Oxides

11/2007R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
1/2007Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
5/2002Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Lars Matuszewski Research Topics

Disease

4Neoplasms (Cancer)
01/2008 - 05/2002
2Fibrosarcoma
12/2007 - 04/2005
2Thrombosis (Thrombus)
12/2007 - 08/2007
1Carcinoma (Carcinomatosis)
11/2007
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2007
1Breast Neoplasms (Breast Cancer)
04/2005
1Body Weight (Weight, Body)
05/2002

Drug/Important Bio-Agent (IBA)

3ferric oxide (iron oxide)IBA
12/2007 - 04/2005
3OxidesIBA
11/2007 - 05/2002
3IronIBA
11/2007 - 05/2002
2ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
12/2007 - 08/2007
11,1'- bis- (4- sulfobutyl)indotricarbocyanine- 5,5'- dicarboxylic acid diglucamideIBA
01/2008
1arginyl-glycyl-aspartic acidIBA
12/2007
1Thromboplastin (Tissue Factor)IBA
12/2007
1gastrin 17 (G 17)IBA
08/2007
1Dextrans (Dextran)FDA Link
04/2005
1CY5.5 cyanine dyeIBA
05/2002
1CathepsinsIBA
05/2002

Therapy/Procedure

2Heterologous Transplantation (Xenotransplantation)
01/2008 - 12/2007
1Aftercare (After-Treatment)
12/2007
1Microspheres (Microsphere)
08/2007